Insulet Total Liabilities and Share Holders Equity 2010-2024 | PODD

Insulet total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Insulet total liabilities and share holders equity for the quarter ending June 30, 2024 was $2.882B, a 20.78% increase year-over-year.
  • Insulet total liabilities and share holders equity for 2023 was $2.588B, a 14.97% increase from 2022.
  • Insulet total liabilities and share holders equity for 2022 was $2.251B, a 9.87% increase from 2021.
  • Insulet total liabilities and share holders equity for 2021 was $2.049B, a 9.39% increase from 2020.
Insulet Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $2,588
2022 $2,251
2021 $2,049
2020 $1,873
2019 $1,143
2018 $929
2017 $817
2016 $457
2015 $275
2014 $297
2013 $288
2012 $198
2011 $221
2010 $156
2009 $173
Insulet Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $2,882
2024-03-31 $2,624
2023-12-31 $2,588
2023-09-30 $2,468
2023-06-30 $2,386
2023-03-31 $2,289
2022-12-31 $2,251
2022-09-30 $2,166
2022-06-30 $2,114
2022-03-31 $2,069
2021-12-31 $2,049
2021-09-30 $1,999
2021-06-30 $1,924
2021-03-31 $1,840
2020-12-31 $1,873
2020-09-30 $1,711
2020-06-30 $1,627
2020-03-31 $1,108
2019-12-31 $1,143
2019-09-30 $1,268
2019-06-30 $978
2019-03-31 $953
2018-12-31 $929
2018-09-30 $886
2018-06-30 $839
2018-03-31 $830
2017-12-31 $817
2017-09-30 $500
2017-06-30 $459
2017-03-31 $445
2016-12-31 $457
2016-09-30 $453
2016-06-30 $263
2016-03-31 $255
2015-12-31 $275
2015-09-30 $293
2015-06-30 $300
2015-03-31 $306
2014-12-31 $297
2014-09-30 $301
2014-06-30 $325
2014-03-31 $289
2013-12-31 $288
2013-09-30 $289
2013-06-30 $286
2013-03-31 $281
2012-12-31 $198
2012-09-30 $203
2012-06-30 $204
2012-03-31 $216
2011-12-31 $221
2011-09-30 $216
2011-06-30 $226
2011-03-31 $149
2010-12-31 $156
2010-09-30 $150
2010-06-30 $162
2010-03-31 $159
2009-12-31 $173
2009-09-30 $117
2009-06-30 $99
2009-03-31 $120
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $18.791B $1.697B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.220B 25.79
Stryker (SYK) United States $143.322B 32.30
Boston Scientific (BSX) United States $130.065B 37.39
Medtronic (MDT) Ireland $112.498B 16.74
EssilorLuxottica (ESLOY) France $111.686B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.423B 0.00
Haleon (HLN) United Kingdom $43.501B 28.26
GE HealthCare Technologies (GEHC) United States $39.264B 20.36
ResMed (RMD) United States $37.048B 30.44
Terumo (TRUMY) Japan $29.575B 41.77
Koninklijke Philips (PHG) Netherlands $25.012B 19.14
Zimmer Biomet Holdings (ZBH) United States $21.536B 13.71
Baxter (BAX) United States $17.673B 11.51
Smith & Nephew SNATS (SNN) United Kingdom $10.619B 0.00
Bio-Rad Laboratories (BIO) United States $10.338B 35.13
BellRing Brands (BRBR) United States $9.136B 38.63
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $6.084B 14.14
Haemonetics (HAE) United States $4.474B 21.43
TG Therapeutics (TGTX) United States $4.460B 0.00
ICU Medical (ICUI) United States $4.318B 41.21
Prestige Consumer Healthcare (PBH) United States $3.983B 19.75
Perrigo (PRGO) Ireland $3.596B 10.59
Neogen (NEOG) United States $3.517B 40.57
Envista Holdings (NVST) United States $3.509B 26.14
Agios Pharmaceuticals (AGIO) United States $3.368B 0.00
GN Store Nord (GNNDY) Denmark $3.041B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.942B 18.94
LeMaitre Vascular (LMAT) United States $2.342B 56.97
Warby Parker (WRBY) United States $1.964B 0.00
Green Thumb Industries (GTBIF) United States $1.888B 33.04
AtriCure (ATRC) United States $1.826B 0.00
InMode (INMD) Israel $1.630B 9.80
Curaleaf Holdings (CURLF) Canada $1.384B 0.00
AdaptHealth (AHCO) United States $1.357B 9.70
Maravai LifeSciences Holdings (MRVI) United States $1.280B 0.00
BioLife Solutions (BLFS) United States $1.206B 0.00
Owens & Minor (OMI) United States $0.995B 7.77
Phibro Animal Health (PAHC) United States $0.966B 17.04
CeriBell (CBLL) United States $0.962B 0.00
National Vision Holdings (EYE) United States $0.906B 30.29
Capricor Therapeutics (CAPR) United States $0.895B 0.00
Evolus (EOLS) United States $0.866B 0.00
Verano Holdings (VRNOF) United States $0.691B 0.00
Cresco Labs (CRLBF) United States $0.605B 0.00
VAREX IMAGING (VREX) United States $0.582B 17.56
Quanterix (QTRX) United States $0.580B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Valneva SE (VALN) France $0.426B 0.00
Canopy Growth (CGC) Canada $0.398B 0.00
ZimVie (ZIMV) United States $0.393B 33.12
Viemed Healthcare (VMD) United States $0.353B 33.59
Cerus (CERS) United States $0.331B 0.00
OraSure Technologies (OSUR) United States $0.320B 21.45
Sanara MedTech (SMTI) United States $0.308B 0.00
Biote (BTMD) United States $0.301B 13.90
Zynex (ZYXI) United States $0.287B 60.07
Jin Medical (ZJYL) China $0.284B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
TerrAscend (TSNDF) Canada $0.269B 0.00
Aurora Cannabis (ACB) Canada $0.264B 0.00
Omeros (OMER) United States $0.256B 0.00
Utah Medical Products (UTMD) United States $0.236B 15.90
High Tide (HITI) Canada $0.221B 91.67
Brainsway (BWAY) Israel $0.181B 217.20
Organigram Holdings (OGI) Canada $0.172B 0.00
FitLife Brands (FTLF) United States $0.151B 20.39
Rockwell Medical (RMTI) United States $0.137B 0.00
TriSalus Life Sciences (TLSI) United States $0.129B 0.00
Quipt Home Medical (QIPT) United States $0.116B 0.00
Zevia PBC (ZVIA) United States $0.111B 0.00
Veru (VERU) United States $0.107B 0.00
Ayr Wellness (AYRWF) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 9.82
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.10
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.67
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.070B 0.00
MariMed (MRMD) United States $0.062B 0.00
Safety Shot (SHOT) United States $0.062B 0.00
Apyx Medical (APYX) United States $0.053B 0.00
Exagen (XGN) United States $0.050B 0.00
Allurion Technologies (ALUR) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.040B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Flora Growth (FLGC) United States $0.017B 0.00
Nephros (NEPH) United States $0.017B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.20
SNDL (SNDL) Canada $0.000B 0.00